.svg){kind=small}
Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Farmaceutical Rx (Frx) has shown varied performance across different product categories in Ohio. In the Edible category, the brand experienced a decline in rankings over the summer months, dropping from 23rd in June to 38th by September. This downward trend was accompanied by a notable decrease in sales, suggesting challenges in maintaining market share in this category. On the other hand, in the Flower category, Frx demonstrated a more resilient performance. Despite a slight dip in July, the brand managed to climb back to 21st place in August, though it slipped again in September. This fluctuation indicates a competitive landscape where Frx is striving to solidify its position.
In the Vapor Pens category, Farmaceutical Rx (Frx) did not appear in the top 30 rankings for most of the summer, finally emerging in 66th place in August. This absence from the top rankings for much of the period highlights a struggle to gain traction in this segment. The lack of a consistent presence in the Vapor Pens category suggests potential areas for strategic improvement or market focus. The overall performance of Frx across these categories in Ohio underscores the brand's need to adapt and innovate to capture and sustain consumer interest in a competitive market environment.
Competitive Landscape
In the competitive landscape of the Ohio flower category, Farmaceutical Rx (Frx) has experienced notable fluctuations in its ranking and sales performance from June to September 2025. Initially ranked 22nd in June, Frx saw a decline to 26th in July, a recovery to 21st in August, but then dropped to 31st by September. This volatility contrasts with the performance of competitors like Firelands Scientific, which maintained a more stable presence, peaking at 21st in July before settling at 30th in September. Meanwhile, Cookies showed a consistent upward trend, improving its rank from 40th in June to 32nd by September, indicating a steady increase in market presence. Classix and Common Citizen also demonstrated competitive dynamics, with Classix rebounding to 33rd in September after a dip, and Common Citizen making a notable entry into the top 20 by September. These shifts highlight the competitive pressures Frx faces, emphasizing the need for strategic adjustments to regain and sustain its market position in Ohio's flower segment.
Notable Products
In September 2025, Black Garlic (2.83g) emerged as the top-performing product for Farmaceutical Rx (Frx), achieving the number one rank with sales of 1032 units. Chem Brulee (2.83g) followed closely as the second best-seller, having climbed up from fourth place in August to secure this position. Runtz Minis (5.66g) debuted in the rankings at third place, while Hot Sauce #9 (2.83g) and Neon Flamingo #6 (2.83g) took the fourth and fifth spots, respectively. Notably, Black Garlic was not ranked in the previous months, indicating a significant surge in popularity. The dynamic shifts in the rankings suggest a competitive market for Farmaceutical Rx (Frx) products, with several new entries making a strong impact.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
